Analysis of the Efficacy of Yiqi Chutan Therapy for Lung Cancer

Zhongjia Yi

doi:10.62051/ijphmr.v2n1.15

Authors

Zhongjia Yi

DOI:

https://doi.org/10.62051/ijphmr.v2n1.15

Keywords:

Yiqi Chutan Therapy, Lung Cancer, Traditional Chinese Medicine, Compound Chinese Herbal Formula

Abstract

Lung cancer has become a major public health problem worldwide, with the highest incidence and mortality rates among malignant tumors. With the emergence of new drugs such as targeted therapy and immunotherapy, the survival rate of lung cancer patients has been extended to some extent, but the overall prognosis is still not satisfactory. In traditional Chinese medicine, Yiqi Chutan therapy is the basic approach for treating lung cancer, which has the functions of reducing toxicity, enhancing efficacy, inhibiting the recurrence and metastasis of lung cancer, improving symptoms, and improving quality of life.

References

[1] MILLER K D, NOGUEIRA L, DEVASIA T, et al. Cancer treatment and survivorship statistics, 2022 [J]. CA Cancer J Clin, 2022,72(5): 409-436.

[2] WANG K, CHEN Q, SHAO Y, et al. Anticancer activities of TCM and their active components against tumor metastasis [J]. Biomed Pharmacother, 2021, 133: 111044.

[3] Xinting Zheng, Lizhu Lin. Observation on the Short-term Therapeutic Effect of Acupuncture and Medication in Treating Advanced-stage and Elderly Non-small Cell Lung Cancer [J]. Inner Mongolia Traditional Chinese Medicine, 2012, 31(12): 1-3.

[4] Jingxu Zhou, Lizhu Lin, and Shumei Wang. Study on the correlation between regulation of vimentin expression and reversal of EMT by Yiqi Chutan Formula [J]. Chinese Medicine Bulletin, 2014, 13(05):60.

[5] Jingxu Zhou, Song Ni, Lingling Sun, et al. Study on the Inhibition of p-AKT Activity and Induction of Apoptosis in A59 Cells by Yiqi Chutan Formula [J]. Journal of Chengdu University of Traditional Chinese Medicine, 2014, 37(02):38.

[6] Lingling Sun, Lizhu Lin. The Effect of Yiqi Chutan Formula on A549 Cell Apoptosis and Expression of Apoptosis-related Genes [J]. Journal of Guangzhou University of Chinese Medicine, 2012, 29(01):49.

[7] Lu Zhuo. Research on the Mechanism of Regulating GRP78-mediated Multiple Signaling Pathways to Inhibit Tumor Angiogenesis by Yiqi Chutan Formula [D]. Guangzhou University of Chinese Medicine, 2017.

[8] Enxin Zhang, Daihan Zhou, Hou Chao. Research on the Inhibition of Anti-Tumor Immune Function of Tumor-Associated Macrophages by Yiqi Chutan Formula [J]. Chinese Journal of Cancer Prevention and Control, 2016, 23(10):627-630, 635.